Corneas were dissected and fixed at room temperature for 1 hour in 1.3% paraformaldehyde in PBS, and radial incisions were made to facilitate flat-mounting of the corneal tissues. Corneas were washed in PBS five times, permeabilized in 1% Triton-X-100 in PBS at room temperature for 60 minutes, and blocked with 20% goat serum (Ceradlan, Burlington, NC, USA) in blocking buffer (0.3% Triton-X-100/0.1% Tween-20 in PBS) for 1 hour. The corneas were then incubated in a 125-μL cocktail of primary antibodies or in 20% normal rabbit serum (Ceradlan) for 2 hours, followed by an additional incubation overnight at 4°C. After five 5-minute washes in wash buffer (0.1% Tween-20 in PBS), the corneas were incubated in a 125-μL cocktail of secondary antibodies and 4′-6-diamidino-2-phenylindole (DAPI, 1:5000; Sigma, St. Louis, MO, USA) in blocking buffer at room temperature for 2 hours. Following five 10-minute washes with wash buffer, the corneas were mounted on slides and dried at 4°C for at least 12 hours before imaging.
Primary antibodies included the following: rabbit polyclonal anti–βIII tubulin (1:1000, cat #ab18207) and chicken polyclonal anti-tyrosine hydroxylase (TH, 1:200, cat #76442) (all from Abcam, Cambridge, MA, USA) or rat anti–substance P (anti-SP, 1:300, cat #556312; BD Bioscience, San Jose, CA, USA). Secondary antibodies included the followoing: Alex Fluor 488 goat anti-rabbit IgG (H+L) (1:500, cat #GR233725-3; Abcam); Alexa Fluor 546 goat anti-chicken IgG (H+L) (1:500, cat #1618409; Life Technologies, Grand Island, NY, USA); Alexa Fluor 633 goat anti-rat IgG (H+L) (1:500, cat #73B1-1; Molecular Probes, Eugene, OR, USA); and DAPI.